SCHAUMBURG, IL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM, founded in 2008, is a small nonprofit in the Medical Research sector that reported $259K in total revenue in fiscal year 2018. Revenue decreased 11% compared to the prior year. The organization ran a surplus of $99K, a strong 38% operating margin.
THE SOCIETY IS A NATIONAL ALLIANCE OF LEADING ACADEMIC AND COMMUNITY BASED URO-ONCOLOGISTS COMMITTED TO THE FOLLOWING - TO FURTHER UROLOGY RESEARCH AND PHARMACEUTICAL TRIALS, - TO OFFER & PROVIDE FOR THE BEST POSSIBLE APPROACH TO DISEASE EDUCATION AND MANAGEMENT PROVIDING FOR BETTER PATIENT OUTCOMES, - TO PROVIDE EDUCATION FOR THE PROFESSION TO FURTHER THE LEARNINGS CONDUCTED THROUGH THE PROFESSION, - AND TO ALLOW CLINICIANS TO BE AWARE OF EXISTING RESEARCH, WHICH ADVANCES FURTHER CLINICAL EDUCATION AND HYPOTHESES.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $684,500 | $553,700 | +0.2% |
| Expenses | $313,029 | $270,281 | +0.2% |
| Net Income | $371,471 | $283,419 | +0.3% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Viraj A Master MD PhD FACS | President | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Brian Matthew Shuch MD | Treasurer | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Gennady Bratslavsky MD | PAST PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Daniel W Lin MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Adam Stuart Kibel MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Kirsten Lynn Greene MD MS | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Sam S Chang MD MBA | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| W Marston Linehan MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Padraic O'Malley MSc MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Ms Pam Murphy | Executive Dir. | 1.00 |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $684,500 | $313,029 | $1,810,558 | $371,471 |
| 2024 | $553,700 | $270,281 | $1,404,532 | $283,419 |
| 2023 | $332,300 | $237,946 | $1,105,625 | $94,354 |
| 2022 | $626,645 | $183,608 | $1,019,541 | $443,037 |
| 2021 | $219,505 | $154,114 | $560,677 | $65,391 |
| 2020 | $213,800 | $163,220 | $496,527 | $50,580 |
| 2019 | $258,725 | $160,007 | $431,262 | $98,718 |
Compare SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM with other nonprofits in Illinois and across the country.